Cart
sales@molnova.com
Prilocaine
CAS No. 721-50-6
Prilocaine( Prilocaine )
Catalog No. M15759 CAS No. 721-50-6
Prilocaine is a local anesthetic of the amino amide type.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 45 | In Stock |
|
| 50MG | 65 | In Stock |
|
| 100MG | 97 | In Stock |
|
| 200MG | 156 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePrilocaine
-
NoteResearch use only, not for human use.
-
Brief DescriptionPrilocaine is a local anesthetic of the amino amide type.
-
DescriptionPrilocaine is a local anesthetic of the amino amide type.(In Vitro):Prilocaine is more potent in inhibiting the Na,K-ATPase of plasma membranes of LM cells (transformed fibroblasts) at 37 ℃ (43.8 mM) than at 25 ℃ (28.2 mM).
-
In VitroPrilocaine is more potent in inhibiting the Na,K-ATPase of plasma membranes of LM cells (transformed fibroblasts) at 37 ℃ (43.8 mM) than at 25 ℃ (28.2 mM).
-
In Vivo——
-
SynonymsPrilocaine
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium Channel
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number721-50-6
-
Formula Weight220.31
-
Molecular FormulaC13H20N2O
-
Purity>98% (HPLC)
-
SolubilityEthanol: 44 mg/mL (199.71 mM) DMSO: 44 mg/mL (199.71 mM) Water: <1 mg/mL
-
SMILESCC(NCCC)C(NC1=CC=CC=C1C)=O
-
Chemical Nameo-Propionotoluidide, 2-(propylamino)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Eriksson E. Prilocaine. Acta Chir Scand Suppl. 1966;358:1-82.
molnova catalog
related products
-
Procaine
Procaine is a local anesthetic drug of the amino ester group, which acts through multiple targets.
-
CNV1014802 hydrochlo...
CNV1014802 (GSK-1014802, Raxatrigine, Vixotrigine) is a potent, selective Nav1.7 sodium channel blocker.
-
Aconitine
Aconitine is a neurotoxin which activates tetrodotoxin-sensitive Na+ channelsinducing presynaptic depolarization and blocking the release of neurotransmitters.
